Results 21 to 30 of about 8,751,011 (252)

Catheter Ablation of Persistent AF—Where are We Now?

open access: yesReviews in Cardiovascular Medicine, 2023
Persistent atrial fibrillation (AF) is a diverse condition that includes various subtypes and underlying causes of arrhythmia. Progress made in catheter ablation technology in recent years has significantly enhanced the durability of ablation.
Louisa O’Neill   +7 more
doaj   +1 more source

Pulsed Field Ablation (PFA) for Pulmonary Vein Isolation in τhe Treatment οf Atrial Fibrillation: Pulsed Field Ablation

open access: yes, 2022
Pulsed‐field ablation (PFA) is a promising new ablation modality for the treatment of atrial fibrillation (AF). Pulmonary vein isolation (PVI) remains the most frequently used treatment strategy of any AF ablation procedure. A major limitation of current
Pastromas, Sokratis
core  

First worldwide use of pulsed‐field ablation for ventricular tachycardia ablation via a retrograde approach [PDF]

open access: yes, 2023
Introduction: We present the first worldwide use of pulsed‐field ablation (PFA) for ventricular tachycardia (VT) ablation via a retrograde approach. Methods: The patient had previously failed conventional ablation of an intramural circuit underneath the ...

core   +3 more sources

Comparison of ablation procedures: Cryoablation versus pulsed field ablation

open access: yes, 2023
Das Ziel dieser Arbeit besteht darin, einen Studienvergleich von klinischen Ergebnissen innerhalb von 12 Monaten bei einer Behandlung von Vorhofflimmern mittels Kryoablation und gepulster Feldablation durchzuführen.
Friedrich, Lisa
core   +1 more source

Field emission of ZnO nano-structures produced by laser ablation [PDF]

open access: yes, 2010
The thesis describes the development of, and results from, two new laboratory facilities designed to investigate the properties of laser produced plasmas, with in-situ time of flight mass spectrometry, for deposition of ZnO materials for applications as
McLoughlin, Conor
core   +2 more sources

Nanoparticles, nanocrystals, and nanocomposites produced with pulsed laser ablation and their applications [PDF]

open access: yes, 2017
In the last few decades, nanoparticles have become key components in a variety of applications in nanotechnology, nanoengineering, and nanoscience. Pulsed laser ablation in liquids (PLAL) method is frequently preferred for fast and pure nanoparticle ...
Elif Uzcengiz Şimşek   +5 more
core   +1 more source

Myocardial electroporation — an alternative to thermal methods of atrial fibrillation treatment

open access: yesРациональная фармакотерапия в кардиологии, 2023
Atrial fibrillation is one of the most common cardiac arrhythmias. By all estimates, the number of patients with this arrhythmia will only increase. Currently, the main and most used methods for the treatment of atrial fibrillation are radiofrequency and
E. A. Archakov   +4 more
doaj   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Pulsed field ablation: Biophysical principles and practical considerations in atrial fibrillation treatment

open access: yesIndian Pacing and Electrophysiology Journal
Pulsed field ablation (PFA) is an emerging nonthermal ablation modality for the treatment of atrial fibrillation. Unlike conventional thermal energy sources such as radiofrequency and cryoablation, PFA delivers high-voltage pulsed electric fields that ...
Shivaraj Patil   +2 more
doaj   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy